ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Sperm DNA Integrity on In Vitro Cycles (TBA on IVF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01232465
Recruitment Status : Completed
First Posted : November 2, 2010
Results First Posted : March 6, 2014
Last Update Posted : April 11, 2014
Sponsor:
Information provided by (Responsible Party):
Northwell Health

Brief Summary:
Sperm DNA integrity will be measured via the Toluidine Blue Assay (TBA) for patients undergoing In Vitro Fertilization (IVF); the study will determine correlations, if any, between IVF success and sperm DNA integrity.

Condition or disease
Male Infertility Unexplained Infertility Abortion, Habitual

Study Type : Observational
Actual Enrollment : 420 participants
Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Impact of Sperm DNA Integrity on In Vitro Cycles
Study Start Date : October 2010
Actual Primary Completion Date : February 2013
Actual Study Completion Date : September 2013


Group/Cohort
IVF
those individuals undergoing conventional IVF to inseminate their retrieved eggs
ICSI
those individuals whose eggs were fertilized via intracytoplasmic sperm injection (ICSI)



Primary Outcome Measures :
  1. Pregnancy [ Time Frame: 9 months ]
    detemining whether the sperm sample (tested for DNA integrity) used to insemenate IVF retrieved eggs, results in a live birth


Biospecimen Retention:   Samples Without DNA
slide smears will be kept to observe overall DNA integrity of sperm sample


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
couples undergoing IVF treatement at the Center for Human Reproduction, North Shore University Hospital, Manhasset NY
Criteria

Inclusion Criteria:

  • couple undergoing IVF at the Center for Human Reproduction
  • sperm sample given from partner (not a donor)

Exclusion Criteria:

  • low sperm concentration (<5 million/cc)
  • using a donor sample

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01232465


Locations
United States, New York
Center for Human Reproduction
Manhasset, New York, United States, 11303
Sponsors and Collaborators
Northwell Health
Investigators
Principal Investigator: Avner E Hershlag, MD Center for Human Reproduction

Publications:

Responsible Party: Northwell Health
ClinicalTrials.gov Identifier: NCT01232465     History of Changes
Other Study ID Numbers: 10-249A
First Posted: November 2, 2010    Key Record Dates
Results First Posted: March 6, 2014
Last Update Posted: April 11, 2014
Last Verified: March 2014

Keywords provided by Northwell Health:
sperm DNA integrity
Toluidine blue assay (TBA)
IVF outcome

Additional relevant MeSH terms:
Infertility
Infertility, Male
Abortion, Habitual
Genital Diseases, Male
Genital Diseases, Female
Abortion, Spontaneous
Pregnancy Complications